Search Results - "lung cancer"

RETRACTED: LncRNA MIR210HG Facilitates Non-Small Cell Lung Cancer Progression Through Directly Regulation of miR-874/STAT3 Axis by Liang Bu, Libin Zhang, Mei Tian, Zhoubin Zheng, Huijie Tang, Qiuju Yang

Connect to this object online.

Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system by Gustavo Viani Arruda, Marina Lourenção, Jorge Henrique Caldeira de Oliveira, Julia Simões Correa Galendi, Alexandre Arthur Jacinto

Connect to this object online.

Cáncer de pulmón y tabaco en Asturias: Un estudio de casos y controles Lung cancer and smoking in Asturias, Spain: A case-control study by M. Caicoya, J.A. Mirón

Connect to this object online.

The efficacy of bevacizumab combined with platinum-containing chemotherapy in the treatment of advanced non-small cell lung cancer in China: a systematic review and meta-analysis of randomized clinical trials by Guangsu Han, Chenlu Li, Ping Yi

Connect to this object online.

A comparison of the Charlson comorbidity index derived from medical records and claims data from patients undergoing lung cancer surgery in Korea: a population-based investigation by Seo Hyun-Ju, Yoon Seok-Jun, Lee Sang-Il, Lee Kun, Yun Young, Kim Eun-Jung, Oh In-Hwan

Connect to this object online.

The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a Preclinical Mouse Model of Established Lung Cancer by Jessica A. Moerland, Karen T. Liby

Connect to this object online.

Conventional Western Treatment Combined With Chinese Herbal Medicine Alleviates the Progressive Risk of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study by Tsai-Hui Lin, Shu-I Chen, Yuan-Chih Su, Mei-Chen Lin, Hung-Jen Lin, Hung-Jen Lin, Sheng-Teng Huang, Sheng-Teng Huang, Sheng-Teng Huang, Sheng-Teng Huang, Sheng-Teng Huang, Sheng-Teng Huang

Connect to this object online.

Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort by Sungji Moon, Hae-Young Lee, Jieun Jang, Sue K. Park

Connect to this object online.

N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB1 and CB2 involvement of PI3K and ERK pathways by Yan Hu, Yan Hu, Zhe Zhao, Zhe Zhao, Yuan-Ting Liu, Ze-Cheng Xu, Jing-Yi Li, Jing-Yi Li, Zheng-Yu Yang, Rui-Wang, Yun-Qi Yang, Jia-Hui Zhang, Si-Yuan Qiu, Tao He, Yi-Ying Wu, Sha Liu, Sha Liu

Connect to this object online.

Quercetin Down-regulates IL-6/STAT-3 Signals to Induce Mitochondrial-mediated Apoptosis in a Non-small-cell Lung-cancer Cell Line, A549 by Avinaba Mukherjee, Anisur Rahman Khuda-Bukhsh

Connect to this object online.

Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studies by Ruo-Lin Gao, Jun Song, Li Sun, Zhi-Xuan Wu, Xiao-Fang Yi, Shu-Ling Zhang, Le-Tian Huang, Jie-Tao Ma, Cheng-Bo Han

Connect to this object online.

Impact of the APE1 Redox Function Inhibitor E3330 in Non-Small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion by Rita Manguinhas, Ana S. Fernandes, João G. Costa, Nuno Saraiva, Sérgio P. Camões, Nuno Gil, Rafael Rosell, Matilde Castro, Joana P. Miranda, Nuno G. Oliveira

Connect to this object online.

Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer by Ye Y, Yang Y, Yan L, Zhou L, Yu S, Du Q, Dong X, Yuan Q, Shan L, Guo L

Connect to this object online.

Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway by Shu-yi Chen, Gao-, Qi-jin Shu

Connect to this object online.

miRNA-486 and miRNA-499 in human plasma evaluate the clinical stages of lung cancer and play a role as a tumor suppressor in lung tumorigeneisis not pathogenesis by Youchao Jia, Aimin Zang, Yanguang Feng, Xiao-Fang Li, Ke Zhang, Hefei Li, Ruiyao Wang, Yaning Wei, Ran Huo

Connect to this object online.

Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells by Jisu Jeong, Jiyeon Kim

Connect to this object online.

Postoperative nursing of a patient undergoing left-sided pneumonectomy for lung cancer (1例肺癌患者左全肺切除术后护理体会) by ZHU Yachao (朱娅超), LI Weixia (李维霞), ZHANG Zhiling (张志玲)

Connect to this object online.

Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system by Yifeng Bai, Yifeng Bai, Xiaomei Wang, Xiaomei Wang, Xiaoqin Dai, Xiaoqin Dai, Qinghua Ma, Qinghua Ma, Honglin Hu, Honglin Hu

Connect to this object online.

Human Lung Cancer Risks from Radon - Part III - Evidence of Influence of Combined Bystander and Adaptive Response Effects on Radon Case-Control Studies - A Microdose Analysis by Bobby E. Leonard, Richard E. Thompson, Georgia C. Beecher

Connect to this object online.

PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals by Ji Young Kim, Ji Hye Shin, Mi-Jeong Kim, Bongkum Choi, Yeeun Kang, Jimin Choi, Seo Hyun Kim, Dohee Kwan, Duk-Hwan Kim, Eunyoung Chun, Ki-Young Lee

Connect to this object online.